ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Growth Hormone Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-32F17025
Home | Market Reports | Health| Pharmacy
Global Growth Hormone Injection Market Research Report 2024
BUY CHAPTERS

Global Growth Hormone Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32F17025
Report
November 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Genentech Inc
Eli Lily
Pfizer Inc
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical

Growth Hormone Injection Market

The global Growth Hormone Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Growth hormone injection is a drug used to promote human growth and development. The main ingredient is human growth hormone. It exerts its physiological functions by stimulating the liver and other tissues to produce insulin-like growth factor (IGF-1), promotes bone growth, protein synthesis, and affects fat and mineral metabolism, playing a key role in human growth and development.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Growth Hormone Injection leading manufacturers including Novo Nordisk, Genentech, Eli Lily, Pfizer, Shree Venkatesh International Limited, LG Chem, Anhui Anke Biotechnology, Zhongshan Sinobioway Hygene Biomedicine, Shanghai United Cell Biotechnology, Changchun GeneScience Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Novo Nordisk leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Growth Hormone Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Growth Hormone Injection Market Report

Report Metric Details
Report Name Growth Hormone Injection Market
Segment by Type
  • Long-acting Water Injection
  • Short-acting Water Injection
  • Short-acting Powder Injection
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Genentech, Eli Lily, Pfizer, Shree Venkatesh International Limited, LG Chem, Anhui Anke Biotechnology, Zhongshan Sinobioway Hygene Biomedicine, Shanghai United Cell Biotechnology, Changchun GeneScience Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Growth Hormone Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Growth Hormone Injection Market report?

Ans: The main players in the Growth Hormone Injection Market are Novo Nordisk, Genentech, Eli Lily, Pfizer, Shree Venkatesh International Limited, LG Chem, Anhui Anke Biotechnology, Zhongshan Sinobioway Hygene Biomedicine, Shanghai United Cell Biotechnology, Changchun GeneScience Pharmaceutical

What are the Application segmentation covered in the Growth Hormone Injection Market report?

Ans: The Applications covered in the Growth Hormone Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Growth Hormone Injection Market report?

Ans: The Types covered in the Growth Hormone Injection Market report are Long-acting Water Injection, Short-acting Water Injection, Short-acting Powder Injection

1 Study Coverage
1.1 Introduction to Growth Hormone Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Growth Hormone Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Long-acting Water Injection
1.2.3 Short-acting Water Injection
1.2.4 Short-acting Powder Injection
1.3 Market Segmentation by Application
1.3.1 Global Growth Hormone Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Growth Hormone Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Growth Hormone Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Growth Hormone Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Growth Hormone Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Growth Hormone Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Growth Hormone Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Long-acting Water Injection Market Size by Manufacturers
3.5.2 Short-acting Water Injection Market Size by Manufacturers
3.5.3 Short-acting Powder Injection Market Size by Manufacturers
3.6 Global Growth Hormone Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Growth Hormone Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Growth Hormone Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Growth Hormone Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Growth Hormone Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Growth Hormone Injection Sales and Revenue by Type (2020-2031)
6.4 North America Growth Hormone Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Growth Hormone Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Growth Hormone Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Growth Hormone Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Growth Hormone Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Growth Hormone Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Growth Hormone Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Growth Hormone Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Growth Hormone Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Growth Hormone Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Growth Hormone Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Growth Hormone Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Growth Hormone Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Growth Hormone Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Growth Hormone Injection Product Models, Descriptions and Specifications
11.1.4 Novo Nordisk Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Novo Nordisk Growth Hormone Injection Sales by Product in 2024
11.1.6 Novo Nordisk Growth Hormone Injection Sales by Application in 2024
11.1.7 Novo Nordisk Growth Hormone Injection Sales by Geographic Area in 2024
11.1.8 Novo Nordisk Growth Hormone Injection SWOT Analysis
11.1.9 Novo Nordisk Recent Developments
11.2 Genentech
11.2.1 Genentech Corporation Information
11.2.2 Genentech Business Overview
11.2.3 Genentech Growth Hormone Injection Product Models, Descriptions and Specifications
11.2.4 Genentech Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Genentech Growth Hormone Injection Sales by Product in 2024
11.2.6 Genentech Growth Hormone Injection Sales by Application in 2024
11.2.7 Genentech Growth Hormone Injection Sales by Geographic Area in 2024
11.2.8 Genentech Growth Hormone Injection SWOT Analysis
11.2.9 Genentech Recent Developments
11.3 Eli Lily
11.3.1 Eli Lily Corporation Information
11.3.2 Eli Lily Business Overview
11.3.3 Eli Lily Growth Hormone Injection Product Models, Descriptions and Specifications
11.3.4 Eli Lily Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Eli Lily Growth Hormone Injection Sales by Product in 2024
11.3.6 Eli Lily Growth Hormone Injection Sales by Application in 2024
11.3.7 Eli Lily Growth Hormone Injection Sales by Geographic Area in 2024
11.3.8 Eli Lily Growth Hormone Injection SWOT Analysis
11.3.9 Eli Lily Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Growth Hormone Injection Product Models, Descriptions and Specifications
11.4.4 Pfizer Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Pfizer Growth Hormone Injection Sales by Product in 2024
11.4.6 Pfizer Growth Hormone Injection Sales by Application in 2024
11.4.7 Pfizer Growth Hormone Injection Sales by Geographic Area in 2024
11.4.8 Pfizer Growth Hormone Injection SWOT Analysis
11.4.9 Pfizer Recent Developments
11.5 Shree Venkatesh International Limited
11.5.1 Shree Venkatesh International Limited Corporation Information
11.5.2 Shree Venkatesh International Limited Business Overview
11.5.3 Shree Venkatesh International Limited Growth Hormone Injection Product Models, Descriptions and Specifications
11.5.4 Shree Venkatesh International Limited Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Shree Venkatesh International Limited Growth Hormone Injection Sales by Product in 2024
11.5.6 Shree Venkatesh International Limited Growth Hormone Injection Sales by Application in 2024
11.5.7 Shree Venkatesh International Limited Growth Hormone Injection Sales by Geographic Area in 2024
11.5.8 Shree Venkatesh International Limited Growth Hormone Injection SWOT Analysis
11.5.9 Shree Venkatesh International Limited Recent Developments
11.6 LG Chem
11.6.1 LG Chem Corporation Information
11.6.2 LG Chem Business Overview
11.6.3 LG Chem Growth Hormone Injection Product Models, Descriptions and Specifications
11.6.4 LG Chem Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 LG Chem Recent Developments
11.7 Anhui Anke Biotechnology
11.7.1 Anhui Anke Biotechnology Corporation Information
11.7.2 Anhui Anke Biotechnology Business Overview
11.7.3 Anhui Anke Biotechnology Growth Hormone Injection Product Models, Descriptions and Specifications
11.7.4 Anhui Anke Biotechnology Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Anhui Anke Biotechnology Recent Developments
11.8 Zhongshan Sinobioway Hygene Biomedicine
11.8.1 Zhongshan Sinobioway Hygene Biomedicine Corporation Information
11.8.2 Zhongshan Sinobioway Hygene Biomedicine Business Overview
11.8.3 Zhongshan Sinobioway Hygene Biomedicine Growth Hormone Injection Product Models, Descriptions and Specifications
11.8.4 Zhongshan Sinobioway Hygene Biomedicine Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments
11.9 Shanghai United Cell Biotechnology
11.9.1 Shanghai United Cell Biotechnology Corporation Information
11.9.2 Shanghai United Cell Biotechnology Business Overview
11.9.3 Shanghai United Cell Biotechnology Growth Hormone Injection Product Models, Descriptions and Specifications
11.9.4 Shanghai United Cell Biotechnology Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Shanghai United Cell Biotechnology Recent Developments
11.10 Changchun GeneScience Pharmaceutical
11.10.1 Changchun GeneScience Pharmaceutical Corporation Information
11.10.2 Changchun GeneScience Pharmaceutical Business Overview
11.10.3 Changchun GeneScience Pharmaceutical Growth Hormone Injection Product Models, Descriptions and Specifications
11.10.4 Changchun GeneScience Pharmaceutical Growth Hormone Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Changchun GeneScience Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Growth Hormone Injection Industry Chain
12.2 Growth Hormone Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Growth Hormone Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Growth Hormone Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Growth Hormone Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Growth Hormone Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Novo Nordisk
Genentech Inc
Eli Lily
Pfizer Inc
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
List of Tables
 Table 1. Global Growth Hormone Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Growth Hormone Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Growth Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Growth Hormone Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Growth Hormone Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Growth Hormone Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Growth Hormone Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Growth Hormone Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Growth Hormone Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Growth Hormone Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Growth Hormone Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Growth Hormone Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Growth Hormone Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Growth Hormone Injection as of 2024)
 Table 16. Global Growth Hormone Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Growth Hormone Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Growth Hormone Injection Manufacturing Base and Headquarters
 Table 19. Global Growth Hormone Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Growth Hormone Injection Sales by Type (2020-2025) & (K Units)
 Table 23. Global Growth Hormone Injection Sales by Type (2026-2031) & (K Units)
 Table 24. Global Growth Hormone Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Growth Hormone Injection Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Growth Hormone Injection ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Growth Hormone Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Growth Hormone Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Growth Hormone Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Growth Hormone Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Growth Hormone Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Growth Hormone Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Growth Hormone Injection Growth Accelerators and Market Barriers
 Table 37. North America Growth Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Growth Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Growth Hormone Injection Growth Accelerators and Market Barriers
 Table 40. Europe Growth Hormone Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Growth Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Growth Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Growth Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Growth Hormone Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Growth Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Growth Hormone Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Growth Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Growth Hormone Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Growth Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Novo Nordisk Corporation Information
 Table 51. Novo Nordisk Description and Major Businesses
 Table 52. Novo Nordisk Product Models, Descriptions and Specifications
 Table 53. Novo Nordisk Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Novo Nordisk Sales Value Proportion by Product in 2024
 Table 55. Novo Nordisk Sales Value Proportion by Application in 2024
 Table 56. Novo Nordisk Sales Value Proportion by Geographic Area in 2024
 Table 57. Novo Nordisk Growth Hormone Injection SWOT Analysis
 Table 58. Novo Nordisk Recent Developments
 Table 59. Genentech Corporation Information
 Table 60. Genentech Description and Major Businesses
 Table 61. Genentech Product Models, Descriptions and Specifications
 Table 62. Genentech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Genentech Sales Value Proportion by Product in 2024
 Table 64. Genentech Sales Value Proportion by Application in 2024
 Table 65. Genentech Sales Value Proportion by Geographic Area in 2024
 Table 66. Genentech Growth Hormone Injection SWOT Analysis
 Table 67. Genentech Recent Developments
 Table 68. Eli Lily Corporation Information
 Table 69. Eli Lily Description and Major Businesses
 Table 70. Eli Lily Product Models, Descriptions and Specifications
 Table 71. Eli Lily Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Eli Lily Sales Value Proportion by Product in 2024
 Table 73. Eli Lily Sales Value Proportion by Application in 2024
 Table 74. Eli Lily Sales Value Proportion by Geographic Area in 2024
 Table 75. Eli Lily Growth Hormone Injection SWOT Analysis
 Table 76. Eli Lily Recent Developments
 Table 77. Pfizer Corporation Information
 Table 78. Pfizer Description and Major Businesses
 Table 79. Pfizer Product Models, Descriptions and Specifications
 Table 80. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Pfizer Sales Value Proportion by Product in 2024
 Table 82. Pfizer Sales Value Proportion by Application in 2024
 Table 83. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 84. Pfizer Growth Hormone Injection SWOT Analysis
 Table 85. Pfizer Recent Developments
 Table 86. Shree Venkatesh International Limited Corporation Information
 Table 87. Shree Venkatesh International Limited Description and Major Businesses
 Table 88. Shree Venkatesh International Limited Product Models, Descriptions and Specifications
 Table 89. Shree Venkatesh International Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Shree Venkatesh International Limited Sales Value Proportion by Product in 2024
 Table 91. Shree Venkatesh International Limited Sales Value Proportion by Application in 2024
 Table 92. Shree Venkatesh International Limited Sales Value Proportion by Geographic Area in 2024
 Table 93. Shree Venkatesh International Limited Growth Hormone Injection SWOT Analysis
 Table 94. Shree Venkatesh International Limited Recent Developments
 Table 95. LG Chem Corporation Information
 Table 96. LG Chem Description and Major Businesses
 Table 97. LG Chem Product Models, Descriptions and Specifications
 Table 98. LG Chem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. LG Chem Recent Developments
 Table 100. Anhui Anke Biotechnology Corporation Information
 Table 101. Anhui Anke Biotechnology Description and Major Businesses
 Table 102. Anhui Anke Biotechnology Product Models, Descriptions and Specifications
 Table 103. Anhui Anke Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Anhui Anke Biotechnology Recent Developments
 Table 105. Zhongshan Sinobioway Hygene Biomedicine Corporation Information
 Table 106. Zhongshan Sinobioway Hygene Biomedicine Description and Major Businesses
 Table 107. Zhongshan Sinobioway Hygene Biomedicine Product Models, Descriptions and Specifications
 Table 108. Zhongshan Sinobioway Hygene Biomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Zhongshan Sinobioway Hygene Biomedicine Recent Developments
 Table 110. Shanghai United Cell Biotechnology Corporation Information
 Table 111. Shanghai United Cell Biotechnology Description and Major Businesses
 Table 112. Shanghai United Cell Biotechnology Product Models, Descriptions and Specifications
 Table 113. Shanghai United Cell Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Shanghai United Cell Biotechnology Recent Developments
 Table 115. Changchun GeneScience Pharmaceutical Corporation Information
 Table 116. Changchun GeneScience Pharmaceutical Description and Major Businesses
 Table 117. Changchun GeneScience Pharmaceutical Product Models, Descriptions and Specifications
 Table 118. Changchun GeneScience Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Changchun GeneScience Pharmaceutical Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Growth Hormone Injection Product Picture
 Figure 2. Global Growth Hormone Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Long-acting Water Injection Product Picture
 Figure 4. Short-acting Water Injection Product Picture
 Figure 5. Short-acting Powder Injection Product Picture
 Figure 6. Global Growth Hormone Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Growth Hormone Injection Report Years Considered
 Figure 11. Global Growth Hormone Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Growth Hormone Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Growth Hormone Injection Revenue Market Share by Region (2020-2031)
 Figure 15. Global Growth Hormone Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Growth Hormone Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Growth Hormone Injection Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Growth Hormone Injection Sales Volume Market Share in 2024
 Figure 19. Global Growth Hormone Injection Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Long-acting Water Injection Revenue Market Share by Manufacturer in 2024
 Figure 22. Short-acting Water Injection Revenue Market Share by Manufacturer in 2024
 Figure 23. Short-acting Powder Injection Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Growth Hormone Injection Sales Market Share by Type (2020-2031)
 Figure 25. Global Growth Hormone Injection Revenue Market Share by Type (2020-2031)
 Figure 26. Global Growth Hormone Injection Sales Market Share by Application (2020-2031)
 Figure 27. Global Growth Hormone Injection Revenue Market Share by Application (2020-2031)
 Figure 28. North America Growth Hormone Injection Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Growth Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Growth Hormone Injection Sales Revenue (US$ Million) in 2024
 Figure 31. North America Growth Hormone Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Growth Hormone Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Growth Hormone Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Growth Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Growth Hormone Injection Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Growth Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Growth Hormone Injection Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Growth Hormone Injection Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Growth Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Growth Hormone Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Growth Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 46. France Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Growth Hormone Injection Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Growth Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Growth Hormone Injection Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Growth Hormone Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Growth Hormone Injection Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Growth Hormone Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Growth Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 61. India Growth Hormone Injection Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Growth Hormone Injection Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Growth Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Growth Hormone Injection Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Growth Hormone Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Growth Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Growth Hormone Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Growth Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Growth Hormone Injection Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Growth Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Growth Hormone Injection Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Growth Hormone Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Growth Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Growth Hormone Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Growth Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Growth Hormone Injection Revenue (2020-2025) & (US$ Million)
 Figure 82. Growth Hormone Injection Industry Chain Mapping
 Figure 83. Regional Growth Hormone Injection Manufacturing Base Distribution (%)
 Figure 84. Global Growth Hormone Injection Production Market Share by Region (2020-2031)
 Figure 85. Growth Hormone Injection Production Process
 Figure 86. Regional Growth Hormone Injection Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Human Growth Hormone Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone Treatment and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Growth Hormone Injections Market Research Report 2024
Global Human Growth Hormone Market Research Report 2025
Global Recombinant Human Somatropin for Injection Market Research Report 2024
Global Synthetic Human Growth Hormone Market Insights Forecast to 2030
Global Prefilled Human Growth Hormone Injection Market Research Report 2024
Global Pediatric Growth Hormone Market Research Report 2025
Global Recombinant Growth Hormone Market Research Report 2024
Global Somatostatin for Injection Market Research Report 2024
Global Growth Hormone Disorder Treatment Market Research Report 2025
Global Growth Hormone Drug Market Research Report 2024
Growth Disorder Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Growth Hormone Market Research Report 2025
Acromegaly Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone Deficiency Ghd Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatocyte Growth promoting Hormone for Injection Market Research Report 2024
Acromegaly Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Growth Hormone ELISA Kit Market Research Report 2024

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions